Psychedelic Stocks Archives - Page 36 of 61

ThursdayJan 19, 2023 12:20 pm

Legislators in Washington File Measure to Legalize Magic Mushrooms

Washington state may be one step closer to launching a legal market for magic mushrooms after bipartisan senators filed a bill to legalize psychedelic mushrooms this year. Lawmakers first introduced an earlier version of the psilocybin legalization bill in January 2022, but it had fewer cosponsors and failed to get any traction. Senator Jesse Salomon reintroduced the legislation last week, unveiling a revised version of the bill with 20 cosponsors. The bill seeks to legalize magic mushrooms in Washington and regulate a psilocybin market for adults aged 21 and older. According to language from the revised bill, its objective is…

WednesdayJan 18, 2023 11:52 am

States Pursuing Psychedelic Reform in 2023

Legislators in various states in the country are working to advance psychedelic reform during the 2023 session. The proposals introduced range from the decriminalization of natural plants and fungi to the legalization of psilocybin for therapeutic use. Below is an overview of some of the measures lawmakers plan to advance in their respective jurisdictions. Connecticut Rep. David Michel recently introduced a psychedelics measure that would legalize the use of psilocybin for therapeutic and medicinal purposes. In a recent phone interview, Michel explained that the decriminalization of these substances would stop certain communities from being targeted, adding that nature-based approaches had…

TuesdayJan 17, 2023 1:31 pm

Study Finds Ethnicity, Race Linked to Mental Health Outcomes and Psychedelic Use

Psychedelics have become popular in the recent times, with growing evidence showing that the substances may be beneficial in the treatment of mental health disorders such as anxiety and depression. One such study found that the administration of psychedelics was linked to significant improvements in anxiety and depression symptoms as well as increased emotional well-being. Now, a new study has discovered that ethnicity and race moderate the link between major depressive episodes and the use of psychedelic drugs. Grant M. Jones, a Harvard University clinical psychology PhD student and the author of the study, revealed that the main objective was…

FridayJan 13, 2023 11:15 am

Colorado to Appoint Psychedelics Advisory Board Members as State Implements Ballot Measure Provisions

Officials in Colorado are seeking people to join its first psychedelics advisory board, which will inform the state on how to implement psychedelics legalization after voters approved a reform measure on last year’s ballot. The state’s Department of Regulatory Agencies has provided a web page where individuals can fill out applications to be considered. Applicants will be required to provide information on their basic background and qualifications. The Natural Medicine Advisory Board will have 15 members, all of whom will be appointed by Governor Jared Polis. The board members will be responsible for ensuring that research is conducted on psychedelics…

ThursdayJan 12, 2023 1:51 pm

Tips for Talking to Your Teenagers About Psychedelics

Psychedelics have become increasingly popular, with more studies finding that the substances may have therapeutic benefits for a range of mental health disorders. While this is positive, their adoption into mainstream media also increases the risk of teens consuming these drugs in the name of experimentation. For example, data from a 2021 survey conducted by the University of Michigan found that roughly 10% of 8th graders, 19% of 10th graders and more than 30% of 12th graders has used illegal drugs in the last year. A separate survey by NIDA also found that a percentage of teens had consumed MDMA,…

WednesdayJan 11, 2023 10:38 am

Second MAPS Phase 3 Clinical Trial Confirms Positive MDMA Results

A growing body of research has revealed that psychedelic drugs such as psilocybin and MDMA have the potential to alleviate a variety of mental illnesses. Decades of federal prohibition made it nigh impossible for scientists to research the possible medical applications of psychedelics, but there has been an upsurge in psychedelic research over the past couple of years. Early results have been extremely encouraging, with clinical studies finding that psychedelics can cause profound changes in mental health and perception when paired with psychotherapy. The Multidisciplinary Association For Psychedelic Studies (MAPS) is at the helm of the first-ever phase 3 clinical…

TuesdayJan 10, 2023 1:33 pm

Ketamine, Smiling Faces Combo Hold Promise in Treating Depression

Early research and clinical trials have revealed that psychedelics can have significant mental health benefits when paired with psychotherapy. Researchers have found that hallucinogenic drugs such as ketamine and psilocybin can be effective against severe mental illnesses, including post-traumatic stress disorder, depression and eating disorders. Furthermore, psychedelic drugs deliver these benefits without the side effects that are often seen in pharmaceutical medications. Given that the field of psychedelic research is largely in its infancy, researchers across the world are still studying psychedelic drugs and trying to figure out how to implement them in mental health therapies. A recently published study…

MondayJan 09, 2023 11:12 am

BMI Doesn’t Impact Intensity of Psychedelic Experiences

New research has found that the intensity of a psilocybin trip doesn’t depend on an individual’s body mass index (BMI). BMI is a measure of body fat based on height and weight that applies to adults. Psilocybin is the primary psychoactive compound found in hallucinogenic mushrooms. When ingested, this compound acts as a receptor agonist of 5-HT2A to activate serotonin receptors in the prefrontal cortex in the brain. This decreases the energy required by the brain to alternate between different activity states. A Center for Psychedelic Research research associate, Meg J. Spriggs, the author of the study, stated that the…

FridayJan 06, 2023 11:44 am

Controlled Study Shows Single Modest Psilocybin Dose Cuts Depression Symptoms for a Fortnight

New research has found that one dose of psilocybin administered together with therapy significantly alleviates symptoms of depression. Psilocybin is the primary psychoactive compound found in magic mushrooms. This compound, which alters an individual’s state of consciousness when consumed, has been used for centuries in religious and spiritual rituals. In the last few years, numerous studies on psilocybin have been conducted to determine its potential therapeutic benefits. While promising results have been observed when the substance is used in managing anxiety and depression, more studies are required to fully understand the effectiveness of psilocybin therapy. The latest study, carried out…

ThursdayJan 05, 2023 1:39 pm

New York Legislators File Measure to Legalize Psychedelics

Last week, legislators in New York filed a measure to legalize psychedelics such as ibogaine and psilocybin for the 2023 legislative session. The bill, which will be introduced formally this week, is being sponsored by assembly members Linda Rosenthal, Karines Reyes and Jo Anne Simon. The bill would make the use, possession, cultivation, creation, production, gifting, analysis, sharing or exchange of natural fungus or plant-based hallucinogens legal for individuals aged 21 and above. The psychedelics that will be legalized if the bill is approved include psilocybin, mescaline, psilocyn, ibogaine and DMT. The bill will also allow individuals to use the…

News and publishing service for psychedelic related companies

Contact us: 512.354.7000

Category: Psychedelic Stocks